Further studies are required to determine the effect of the etiology of the disease on the GP73 signal strength, the diagnostic accuracy of GP73 in detecting early HCC or cancer recurrence and the value of a combination of GP73 and AFP. This evidence concerns the gene AFP and hepatocellular carcinoma.